Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

1 Citations

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1571980075316643840
  • NII Article ID
    10018174265
  • Data Source
    • CiNii Articles

Report a problem

Back to top